Quyen Schwing, MS

Senior Team Leader, Global Pharmaceutical R&D
Ashland Specialty Ingredients

Poster(s):

• (M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
  Monday, October 21, 2024

  9:30 AM – 10:30 AM MT

• (M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
  Monday, October 21, 2024

  12:30 PM – 1:30 PM MT

• (M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
  Monday, October 21, 2024

  12:30 PM – 1:30 PM MT

• (T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT

• (T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT